UK HealthTech startup raises £3 million

Written by Hannah McGrath

Healthera, a Cambridge-based digital health startup, has just raised £3 million in series A funding.

Founded in 2015 by chief executive Quintus Liu and fellow Cambridge alumni Martin Hao and Jin Dai during their last year of study, Healthera connects patients to a platform of pharmacies and NHS GPs, allowing them to track and order prescriptions, access services and monitor their medication intake in one digital service.

The company claims to connect tens of thousands of patients to more than 500 pharmacies and is forming partnerships with NHS local authorities (CCG), with a particular focus on its app, which is listed on the NHS digital apps library.

The company’s NHS-funded patient benefit research with Cambridge University’s Institute of Public is further evidence of its growing foothold in public healthcare infrastructure.

The founders hope Healthera will digitise health management and facilitate communication for the 98 per cent of patients, pharmacies and GPs who still rely on manual and less efficient methods of interaction. While the initial focus is helping patients order repeat prescriptions, the company claims its growing dataset offers potential for expansion into over-the-counter drugs and pharmaceutical insight.

Liu says that the £3 million investment, led by ADV with participation from Cambridge Enterprise - the university’s commercial arm - will be used to accelerate plans to expand the company’s user base to households and patients across a multiple healthcare verticals in the UK and further afield.

Mike Dimelow, chief investment officer at ADV, said: “Repeat medical prescriptions are used by millions in the UK each year and many more across the world.

“Paperwork, physical appointments and lack of focus on patient’s needs make this an all too often inefficient process for all involved. Healthera is tackling this by bringing clinical services, prescription and medicine intake monitoring in one consumer platform which has seen rapid uptake from pharmacists and patients.”

Related Articles